These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4845133)

  • 1. Muscle syndrome with clofibrate usage.
    Kra SJ
    Conn Med; 1974 Jul; 38(7):348-9. PubMed ID: 4845133
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clofibrate-induced muscle problems].
    Bojs G; Fahlén M; Lapidus L
    Lakartidningen; 1979 Jul; 76(30-31):2631-2. PubMed ID: 529902
    [No Abstract]   [Full Text] [Related]  

  • 3. Clofibrate-induced muscular syndrome. Case report with ultrastructural findings and review of the literature.
    Rimon D; Ludatscher R; Cohen L
    Isr J Med Sci; 1984 Nov; 20(11):1082-6. PubMed ID: 6511338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The adverse actions of clofibrate in chronic hemodialysis patients--acute muscular syndrome and others (author's transl)].
    Kijima Y; Makise J; Sasaoka T; Kanayama M; Kubota S
    Nihon Jinzo Gakkai Shi; 1978 Sep; 20(9):955-66. PubMed ID: 713172
    [No Abstract]   [Full Text] [Related]  

  • 5. Creatinekinase in hyperlipoproteinemic patients treated with clofibrate.
    Schneider J; Mühlfellner G; Kaffarnik H
    Artery; 1980; 8(2):164-70. PubMed ID: 7458683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical muscular syndrome with myolysis during long-term treatment with fibrates].
    Chauvin M; Zupan M; Brechenmacher C
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):921-3. PubMed ID: 3142389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical importance of clofibrate induced increase of creatine kinase catalytic activity concentration in serum.
    Schneider J
    J Clin Chem Clin Biochem; 1981 Aug; 19(8):539-40. PubMed ID: 7276838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofibrate myopathy: a case report and a review of the literature.
    Rush P; Baron M; Kapusta M
    Semin Arthritis Rheum; 1986 Feb; 15(3):226-9. PubMed ID: 3515563
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscular syndrome after clofibrate.
    Katsilambros N; Braaten J; Ferguson BD; Bradley RF
    N Engl J Med; 1972 May; 286(20):1110-1. PubMed ID: 5018870
    [No Abstract]   [Full Text] [Related]  

  • 10. Clofibrate-induced muscular syndrome. Report of a case with clinical, electromyographic and pathologic observations.
    Abourizk N; Khalil BA; Bahuth N; Afifi AK
    J Neurol Sci; 1979 Jun; 42(1):1-9. PubMed ID: 448390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofibrate-induced acute muscular syndrome.
    Sekowski I; Samuel P
    Am J Cardiol; 1972 Oct; 30(5):572-4. PubMed ID: 5073673
    [No Abstract]   [Full Text] [Related]  

  • 12. Clofibrate-induced complications in renal disease: a case report.
    Pokroy N; Ress S; Gregory MC
    S Afr Med J; 1977 Nov; 52(20):806-8. PubMed ID: 204061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofibrate treatment of neonatal jaundice.
    Erkul I; Yavuz H; Ozel A
    Pediatrics; 1991 Dec; 88(6):1292-4. PubMed ID: 1956756
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Clofibrate-induced myopathy syndrome.
    Rumpf KW; Albers R; Scheler F
    Lancet; 1976 Jan; 1(7953):249-50. PubMed ID: 55556
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofibrate-induced muscle damage with myoglobinuria and cardiomyopathy.
    Smals AG; Beex LV; Kloppenborg PW
    N Engl J Med; 1977 Apr; 296(16):942. PubMed ID: 846520
    [No Abstract]   [Full Text] [Related]  

  • 16. Clofibrate, nephrotic syndrome, and histological changes in muscle.
    Denizot M; Fabre J; Pometta D; Wildi E
    Lancet; 1973 Jun; 1(7815):1326. PubMed ID: 4126124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome].
    Fabre J; Denizot M; Wildi E; Micheli H; Berthoud S
    Schweiz Rundsch Med Prax; 1973 Jun; 62(23):732-7. PubMed ID: 4705828
    [No Abstract]   [Full Text] [Related]  

  • 18. Clofibrate-induced myopathy in a patient with primary hypothyroidism.
    Hattori N; Shimatsu A; Murabe H; Nishimura M; Nakamura H; Imura H
    Jpn J Med; 1990; 29(5):545-7. PubMed ID: 2089182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofibrate-induced myopathy in patients with diabetes insipidus.
    Matsukura S; Matsumoto J; Chihara K; Yoshimoto Y; Fujita T
    Endocrinol Jpn; 1980 Jun; 27(3):401-3. PubMed ID: 7439122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untoward effects of clofibrate in hemodialyzed patients.
    Kijima Y; Sasaoka T; Kanayama M; Kubota S
    N Engl J Med; 1977 Mar; 296(9):515. PubMed ID: 834232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.